Successful completion of first trial phase enables continued pivotal trial of FemBloc, the only non-surgical permanent birth control, toward U.S. FDA approval -- -- $12 million senior secured ...
Femasys (FEMY) on Monday said that the FDA approved continuation of the final phase of its FemBloc pivotal trial, sending shares 25% higher in premarket trading. This milestone follows the successful ...
The U.S. has conducted15 strikes on alleged drug vessels since early September, killing 64 people. Plus, President Donald Trump is accusing Nigeria’s government of allowing the killing of Christians.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback